Are These 3 Beaten-Down S&P 500 Members Worth a Look?
https://www.zacks.com/commentary/2241645/are-these-3-beaten-down-s-p-500-members-worth-a-look?cid=CS-ZC-FT-investment_ideas-2241645
Mar 15, 2024 - The market has enjoyed a fantastic run in 2024, building nicely on last year???s gains. But not all have joined the party, specifically these three. Deep in the red year-to-date, are they worth a look?
0
Why Elevance (ELV) is a Smart Addition to Your Portfolio Now
https://www.zacks.com/stock/news/2241626/why-elevance-elv-is-a-smart-addition-to-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2241626
Mar 15, 2024 - Elevance's (ELV) top line is poised to gain from rising product revenues, administrative fees and other revenues.
0
The Joint (JYNT) Rises 30% as Q4 Earnings Beat on Higher Clinics
https://www.zacks.com/stock/news/2238726/the-joint-jynt-rises-30-as-q4-earnings-beat-on-higher-clinics?cid=CS-ZC-FT-analyst_blog|earnings_article-2238726
Mar 11, 2024 - The Joint (JYNT) expects 2024 system-wide sales to be within $530-$545 million.
0
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
https://www.zacks.com/stock/news/2238612/are-you-a-value-investor-this-1-stock-could-be-the-perfect-pick?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2238612
Mar 11, 2024 - The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
0
3 Top-Ranked Stocks to Buy for Stability
https://www.zacks.com/commentary/2236265/3-top-ranked-stocks-to-buy-for-stability?cid=CS-ZC-FT-investment_ideas-2236265
Mar 05, 2024 - Targeting low-beta stocks can provide a valuable layer of stability for portfolios. After all, defense wins ballgames.
0
HCA Healthcare (HCA) Rises 24.8% in a Year: More Room to Run?
https://www.zacks.com/stock/news/2236168/hca-healthcare-hca-rises-24-8-in-a-year-more-room-to-run?cid=CS-ZC-FT-analyst_blog|price_surge_/_plunge-2236168
Mar 05, 2024 - HCA Healthcare's (HCA) growing equivalent admissions are supporting performance.
0
The Joint (JYNT) to Report Q4 Earnings: Here Are the Key Drivers
https://www.zacks.com/stock/news/2236169/the-joint-jynt-to-report-q4-earnings-here-are-the-key-drivers?cid=CS-ZC-FT-analyst_blog|earnings_preview-2236169
Mar 05, 2024 - The Joint's (JYNT) fourth-quarter 2023 results are likely to reflect higher expenses and patient volumes.
0
Centene (CNC), Pyx Health Unite to Treat Mental Health Issues
https://www.zacks.com/stock/news/2234855/centene-cnc-pyx-health-unite-to-treat-mental-health-issues?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2234855
Mar 01, 2024 - Centene (CNC) partners with Pyx Health to address loneliness and mental health issues among the insured.
0
Why Cigna (CI) is a Top Momentum Stock for the Long-Term
https://www.zacks.com/stock/news/2233930/why-cigna-ci-is-a-top-momentum-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_momentum_score-2233930
Feb 29, 2024 - Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
0
Cigna (CI) Upgraded to Buy: What Does It Mean for the Stock?
https://www.zacks.com/stock/news/2228719/cigna-ci-upgraded-to-buy-what-does-it-mean-for-the-stock?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_12_zacks_rank_upgrade-2228719
Feb 20, 2024 - Cigna (CI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
0